A Study at the Center of the Abortion Pill Battle Was Just Retracted
A scientific publisher found serious flaws in a paper that links the medication mifepristone to more emergency room visits. ..
A scientific publisher found serious flaws in a paper that links the medication mifepristone to more emergency room visits. ..
CAR-T cell therapy harnesses the immune system to attack blood cancers. Six years after approving the first treatment, the FDA is investigating whether ..
People with ADHD have been dealing with a stimulant shortage in the US for almost a year. Some researchers say digital therapeutics could help fill the gap. ..
Current treatments for depression after giving birth are either slow to work or hard to get. The FDA is considering a new tablet that relieves symptoms ..
By early 2024, a tablet called Opill will be sold in pharmacies without a prescription, making it easier for uninsured and young buyers to access. ..
Three years ago, the FDA declared a manufacturing free-for-all. Now a noxious brew of leftover product is catching fire and making people sick. ..
The nation’s highest court temporarily stayed restrictions on the drug mifepristone while it continues weighing a decision. ..
Flu meds and prescription drugs have been in short supply all winter—but the problem goes back over a decade. ..
The US regulatory body has signed off on Upside Foods’ cultivated meat—but the company is still figuring out how to make enough of it to sell. ..
Under the Constitution, federal laws overrule state ones. But challenges to medication abortion will test the agency’s ability to make nationwide regulations. ..